Glyciphage-VG1 Tablet SR
By Glyciphage-VG
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Franco-Indian Pharmaceuticals Pvt Ltd
20, Dr. E. Moses Road, Mahalaxmi, Mumbai - 400 011

Expires on or after
January, 2026

liver
Glyciphage-VG1 Tablet SR should be used carefully in individuals with liver issues. It may be necessary to adjust the dosage of Glyciphage-VG1 Tablet SR in such cases. It is advised to seek guidance from your healthcare provider before using this medication. Typically, Glyciphage-VG1 Tablet SR is initiated at a low dose for patients with mild to moderate liver problems. However, it is not recommended for use in individuals with severe liver disease.

kidney
Glyciphage-VG1 Tablet SR may not be safe for patients with kidney disease and is not recommended for those with severe kidney issues. Consult your doctor before use.

alcohol
It is unsafe to consume alcohol with Glyciphage-VG1 Tablet SR. Avoid alcohol when taking this medication. Caution - Pregnancy It is important to consult your doctor regarding alcohol consumption with Glyciphage-VG1 Tablet SR during pregnancy.

driving
To ensure safety, avoid driving if experiencing low or high blood sugar symptoms while taking Glyciphage-VG1 Tablet SR.

pregnancy
Glyciphage-VG1 Tablet SR may be harmful during pregnancy based on animal studies. Consult your doctor to assess potential risks and benefits before using it.

breastfeeding
Glyciphage-VG1 Tablet SR is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹121.5
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024